Fundamentals for Tissue Regenix Group ( trx )
Current Price: 0.65
Market Cap: 45.52m
Price / Net Assets: 1.5
Internal Rate of Return: 119.41%
PE10 Ratio: -5.89
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Average |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £24.48m | £19.75m | £16.47m | £13.03m | £11.62m | £1.44m | £0.82m | £0.1m | £11m |
| Revenue Growth | 23.95% | 19.91% | 26.40% | 12.13% | 706.94% | 75.61% | 720.00% | - | 226% |
| Profit / Loss | £-2.6m | £-4.99m | £-12.46m | £-7.11m | £-8.26m | £-9.91m | £-9.5m | £-7.58m | £-8m |
| Profit Increase/Decrease | -47.90% | -59.95% | 75.25% | -13.92% | -16.65% | 4.32% | 25.33% | - | -5% |
| Profit / Sales Ratio | - | - | - | - | - | - | - | - | 0% |
| Earnings per Share | £-0.04 | £-0.07 | £-0.28 | £-0.60 | £-0.70 | £-0.01 | £-0.01 | £-0.01 | £-0.22 |
| Total Debt | £15.64m | £12.83m | £12.06m | £5.91m | £5.09m | £2.06m | £1.96m | £1.09m | £7.08m |
| Net Assets | £30.40m | £33.39m | £38.27m | £24.59m | £32.57m | £11.54m | £21.24m | £11.58m | £25.45m |
| Debt / Asset Ratio | 33.97% | 27.76% | 23.96% | 19.38% | 13.52% | 15.15% | 8.45% | 8.60% | 8.60% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |